Scala, First Half Net Income Turns to Profit, Exceeds Full-Year Plan
4845 Scala, Inc. 【IFRS】
Earnings ReportScala, Inc. <4845> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 14th (17:00). The consolidated net income/loss for the cumulative second quarter of the fiscal year ending June 2025 (July to December) turned into a profit of 0.35 billion yen (compared to a loss of 0.24 billion yen in the same period last year). The progress rate toward the full-year plan of 0.34 billion yen is 103.8%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the January to June period (2H) is expected to further decrease loss of 0.01 billion yen (compared to a loss of 2.64 billion yen in the same period last year).
In the most recent three-month period, from October to December (2Q), the consolidated net income/loss turned to a profit of 0.39 billion yen (compared to a loss of 0.14 billion yen in the same period last year). The operating profit/loss margin drastically improved from -4.4% in the same period last year to 11.6%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
6,336M | 136M | 116M | 90M | 5.2 | 31.0 | Feb 14, 2023 | IFRS |
|
|
4,622M | -162M | -176M | -246M | -14.2 | ー | Feb 14, 2024 | IFRS |
|
|
4,179M | 374M | 361M | 353M | 20.4 | 66.9 | Feb 14, 2025 | IFRS |
| YoY | -9.6% | － | － | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 Guidance | ー | ー | ー | ー | － | 8 | Aug 14, 2024 | IFRS |
| Jul - Dec, 2024 Results | 4,179M | 374M | 361M | 353M | 20.4 | 8 | Feb 14, 2025 | IFRS |
| Revision Rate | － | － | － | － | － |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
3,571M | -1,286M | -1,290M | -2,641M | -152.3 | 18.75 | Aug 14, 2024 | IFRS |
|
Guidance
Jan - Jun, 2025
|
5,921M | 176M | 179M | -13M | -0.8 | 8 | Feb 14, 2025 | IFRS |
| YoY | +65.8% | － | － | +99.5% | +99.5% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
11,838M | 397M | 374M | -218M | -12.6 | 37 | Aug 14, 2023 | IFRS |
|
|
8,193M | -1,448M | -1,466M | -2,887M | -166.5 | 37.50 | Aug 14, 2024 | IFRS |
|
Guidance
Jun, 2025
|
10,100M | 550M | 540M | 340M | 19.6 | 16 | Aug 14, 2024 | IFRS |
| YoY | +23.3% | － | － | － | － |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,296M | -100M | -102M | -142M | -8.2 | -4.4 | Feb 14, 2024 | IFRS |
|
|
2,496M | -585M | -596M | -1,381M | -79.7 | -23.4 | May 15, 2024 | IFRS |
|
|
1,075M | -701M | -694M | -1,260M | -72.7 | -65.2 | Aug 14, 2024 | IFRS |
|
|
1,848M | 30M | 19M | -43M | -2.5 | 1.6 | Nov 14, 2024 | IFRS |
|
|
2,331M | 344M | 342M | 396M | 22.9 | 14.8 | Feb 14, 2025 | IFRS |
| YoY | +1.5% | － | － | － | － |
Related Articles
-
NAKAYO, Postponed Dividend for This Fiscal Year
Fri Feb 14, 2025 3:30 pm JST Revision -
f-code, 42% Increase in Net Income, Update Record High for Third Consecutive Term
Fri Feb 14, 2025 5:30 pm JST Earnings -
Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Fri Feb 14, 2025 5:00 pm JST Earnings -
AEON Fantasy, The Current Fiscal Year Net Income Revised Downward to a Loss, Dividend Revised down by 5 yen
Fri Feb 14, 2025 5:00 pm JST Revision -
Rococo Co, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 12% Increase in Ordinary Profit for The Current Fiscal Year
Fri Feb 14, 2025 5:00 pm JST Earnings -
kaihan, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Fri Feb 14, 2025 5:00 pm JST Earnings -
baby calendar, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 60% Increase in Ordinary Profit for The Current Fiscal Year
Fri Feb 14, 2025 5:00 pm JST Earnings -
Daikokuya Holdings, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Fri Feb 14, 2025 5:00 pm JST Earnings -
Kanamic Network, Oct-Dec (1Q) Ordinary Profit Increases by 19%
Fri Feb 14, 2025 5:00 pm JST Earnings -
Nishimoto Co, 47% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Fri Feb 14, 2025 5:00 pm JST Earnings